CIK 0001604821 · Large accelerated filer
Natera, Inc.
Sign in to watch- Ticker
- NTRA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 010894487
- Phone
- 650-249-9090
- Business address
- 13011 MCCALLEN PASS, BUILDING A SUITE 100, AUSTIN, TX, 78753
- Former names
- Natera, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $104,832,418
- in 28 filings, $104.8M under 10b5-1 plans
Net −$104,832,418. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Rabinowitz Matthew −$72.3M EXECUTIVE CHAIRMAN sold 9% of stake
- Sheena Jonathan −$13.8M Director sold 83% of stake
- Moshkevich Solomon −$9.5M PRESIDENT, CLINICALDIAGNOSTICS sold 21% of stake
- Chapman Steven Leonard −$5.0M CEO AND PRESIDENT sold 12% of stake
- Brophy Michael Burkes −$2.5M CHIEF FINANCIAL OFFICER sold 11% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-07 | Sheena Jonathan Director | Sale 10b5-1 | −300 | $193.59 | $58K | 233,460 |
| 2025-11-07 | Sheena Jonathan Director | Sale 10b5-1 | −600 | $196.06 | $118K | 232,860 |
| 2025-11-07 | Sheena Jonathan Director | Sale 10b5-1 | −100 | $196.78 | $20K | 232,760 |
| 2025-11-07 | Sheena Jonathan Director | Sale 10b5-1 | −100 | $198.38 | $20K | 232,660 |
| 2025-11-04 | Rabinowitz Matthew EXECUTIVE CHAIRMAN | Sale 10b5-1 | −17,198 | $200.29 | $3.4M | 2,286,554 |
| 2025-11-04 | Rabinowitz Matthew EXECUTIVE CHAIRMAN | Sale 10b5-1 | −5,702 | $201.18 | $1.1M | 2,280,852 |
| 2025-11-03 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −1,450 | $198.03 | $287K | 113,611 |
| 2025-11-03 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −1,450 | $199.10 | $289K | 112,161 |
| 2025-11-03 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −100 | $199.74 | $20K | 112,061 |
| 2025-11-03 | Marcus Gail Boxer Director | Sale 10b5-1 | −122 | $198.71 | $24K | 5,762 |
| 2025-11-03 | Sheena Jonathan Director | Sale 10b5-1 | −2,000 | $200.14 | $400K | 26,032 |
| 2025-11-03 | Sheena Jonathan Director | Sale 10b5-1 | −2,000 | $200.00 | $400K | 26,032 |
| 2025-11-03 | Chapman Steven Leonard CEO AND PRESIDENT | Option exercise 10b5-1 | +2,084 | $13.01 | $27K | 151,924 |
| 2025-11-03 | Chapman Steven Leonard CEO AND PRESIDENT | Option exercise 10b5-1 | +3,595 | $20.27 | $73K | 155,519 |
| 2025-11-03 | Chapman Steven Leonard CEO AND PRESIDENT | Option exercise 10b5-1 | +150,000 | $119.75 | $18.0M | 305,519 |
| 2025-11-03 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −2,215 | $198.03 | $439K | 303,304 |
| 2025-11-03 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −1,915 | $198.96 | $381K | 301,389 |
| 2025-11-03 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −156,573 | $200.00 | $31.3M | 144,816 |
| 2025-11-03 | Chapman Steven Leonard CEO AND PRESIDENT | Option exercise · Stock Option (right to buy) 10b5-1 | −2,084 | 0 | ||
| 2025-11-03 | Chapman Steven Leonard CEO AND PRESIDENT | Option exercise · Stock Option (right to buy) 10b5-1 | −3,595 | 0 |
Page 34 of 39 · 767 trades